Allen AM, Kamath PS, Larson JJ, et al. Cardiovascular Risk in NAFLD- Not an Equal Opportunity: Implications for Women’s Health. AASLD 2017, abstract 55.
Perioperatief camrelizumab plus rivoceranib bij resectabel HCC met gemiddeld-hoog recidiefrisico
dec 2025 | Chirurgie, Maag-darm-leveroncologie